» Articles » PMID: 19325804

Recent Developments in Peptide-based Nucleic Acid Delivery

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2009 Mar 28
PMID 19325804
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Despite the fact that non-viral nucleic acid delivery systems are generally considered to be less efficient than viral vectors, they have gained much interest in recent years due to their superior safety profile compared to their viral counterpart. Among these synthetic vectors are cationic polymers, branched dendrimers, cationic liposomes and cell-penetrating peptides (CPPs). The latter represent an assortment of fairly unrelated sequences essentially characterised by a high content of basic amino acids and a length of 10-30 residues. CPPs are capable of mediating the cellular uptake of hydrophilic macromolecules like peptides and nucleic acids (e.g. siRNAs, aptamers and antisense-oligonucleotides), which are internalised by cells at a very low rate when applied alone. Up to now, numerous sequences have been reported to show cell-penetrating properties and many of them have been used to successfully transport a variety of different cargos into mammalian cells. In recent years, it has become apparent that endocytosis is a major route of internalisation even though the mechanisms underlying the cellular translocation of CPPs are poorly understood and still subject to controversial discussions. In this review, we will summarise the latest developments in peptide-based cellular delivery of nucleic acid cargos. We will discuss different mechanisms of entry, the intracellular fate of the cargo, correlation studies of uptake versus biological activity of the cargo as well as technical problems and pitfalls.

Citing Articles

A Molecular Dynamics Simulation of Complexes of Fullerenes and Lysine-Based Peptide Dendrimers with and without Glycine Spacers.

Bezrodnyi V, Mikhtaniuk S, Shavykin O, Sheveleva N, Markelov D, Neelov I Int J Mol Sci. 2024; 25(2).

PMID: 38255765 PMC: 10815860. DOI: 10.3390/ijms25020691.


Beyond GalNAc! Drug delivery systems comprising complex oligosaccharides for targeted use of nucleic acid therapeutics.

OSullivan J, Munoz-Munoz J, Turnbull G, Sim N, Penny S, Moschos S RSC Adv. 2022; 12(32):20432-20446.

PMID: 35919168 PMC: 9281799. DOI: 10.1039/d2ra01999j.


Mechanistic Research for the Student or Educator (Part II of II).

Leak R, Schreiber J Front Pharmacol. 2022; 13:741492.

PMID: 35903332 PMC: 9315264. DOI: 10.3389/fphar.2022.741492.


Delivery of Various Cargos into Cancer Cells and Tissues via Cell-Penetrating Peptides: A Review of the Last Decade.

Shoari A, Tooyserkani R, Tahmasebi M, Lowik D Pharmaceutics. 2021; 13(9).

PMID: 34575464 PMC: 8470549. DOI: 10.3390/pharmaceutics13091391.


Peptide-Based Therapeutics for Oncology.

Fisher E, Pavlenko K, Vlasov A, Ramenskaya G Pharmaceut Med. 2020; 33(1):9-20.

PMID: 31933267 DOI: 10.1007/s40290-018-0261-7.


References
1.
Derossi D, Williams E, Green P, Dunican D, Doherty P . Stimulation of mitogenesis by a cell-permeable PI 3-kinase binding peptide. Biochem Biophys Res Commun. 1998; 251(1):148-52. DOI: 10.1006/bbrc.1998.9444. View

2.
Console S, Marty C, Garcia-Echeverria C, Schwendener R, Ballmer-Hofer K . Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans. J Biol Chem. 2003; 278(37):35109-14. DOI: 10.1074/jbc.M301726200. View

3.
Pontiroli A, Alberetto M, Pozza G . Intranasal calcitonin and plasma calcium concentrations in normal subjects. Br Med J (Clin Res Ed). 1985; 290(6479):1390-1. PMC: 1415597. DOI: 10.1136/bmj.290.6479.1390. View

4.
Magzoub M, Sandgren S, Lundberg P, Oglecka K, Lilja J, Wittrup A . N-terminal peptides from unprocessed prion proteins enter cells by macropinocytosis. Biochem Biophys Res Commun. 2006; 348(2):379-85. DOI: 10.1016/j.bbrc.2006.07.065. View

5.
Meade B, Dowdy S . Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides. Adv Drug Deliv Rev. 2007; 60(4-5):530-6. PMC: 2293332. DOI: 10.1016/j.addr.2007.10.004. View